Execs On The Move: New Chief Officers At Nevro And Integra; Cerapedics Adds Development Exec
Nevro, a pain device company, added a chief commercial officer from Abbott Vascular; Integra Lifesciences moved its top finance boss to chief operating officer; a Spinal Kinetics exec joined orthobiologics company Cerapedics to lead its clinical and market development; and more.
You may also be interested in...
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.